Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pneumocystis pneumonia associated with infliximab in Japan.

× No keyword cloud information.

37 in total

Review 1. Update on the diagnosis and treatment of Pneumocystis pneumonia.

Authors: Eva M Carmona; Andrew H Limper
Journal: Ther Adv Respir Dis Date: 2010-08-24 Impact factor: 4.031

2. A fatal case of acute exacerbation of interstitial lung disease in a patient with rheumatoid arthritis during treatment with tocilizumab.

Authors: Shin-Ya Kawashiri; Atsushi Kawakami; Noriho Sakamoto; Yuji Ishimatsu; Katsumi Eguchi
Journal: Rheumatol Int Date: 2010-05-18 Impact factor: 2.631

Review 3. Fungal infection risks associated with the use of cytokine antagonists and immune checkpoint inhibitors.

Authors: Xin Li; Susanna Kp Lau; Patrick Cy Woo
Journal: Exp Biol Med (Maywood) Date: 2020-07-08

4. Glycosphingolipids mediate pneumocystis cell wall β-glucan activation of the IL-23/IL-17 axis in human dendritic cells.

Authors: Eva M Carmona; Theodore J Kottom; Deanne M Hebrink; Teng Moua; Raman-Deep Singh; Richard E Pagano; Andrew H Limper
Journal: Am J Respir Cell Mol Biol Date: 2012-02-16 Impact factor: 6.914

5. Pneumocystis pneumonia complicating immunosuppressive therapy in Crohns disease: A preventable problem?

Authors: Omer Omer; Patrizia Cohen; Shuet Fong Neong; Geoffrey V Smith
Journal: Frontline Gastroenterol Date: 2014-09-22

6. Serologic responses to pneumocystis proteins in HIV patients with and without Pneumocystis jirovecii pneumonia.

Authors: Matthew R Gingo; Lorrie Lucht; Kieran R Daly; Kpandja Djawe; Frank J Palella; Alison G Abraham; Jay H Bream; Mallory D Witt; Lawrence A Kingsley; Karen A Norris; Peter D Walzer; Alison Morris
Journal: J Acquir Immune Defic Syndr Date: 2011-07-01 Impact factor: 3.731

7. Differences in clinical Pneumocystis pneumonia in rheumatoid arthritis and other connective tissue diseases suggesting a rheumatoid-specific interstitial lung injury spectrum.

Authors: Kota Shimada; Kyoko Yokosuka; Takahiro Nunokawa; Shoji Sugii
Journal: Clin Rheumatol Date: 2018-06-06 Impact factor: 2.980

8. Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) study.

Authors: John W Baddley; Kevin L Winthrop; Lang Chen; Liyan Liu; Carlos G Grijalva; Elizabeth Delzell; Timothy Beukelman; Nivedita M Patkar; Fenglong Xie; Kenneth G Saag; Lisa J Herrinton; Daniel H Solomon; James D Lewis; Jeffrey R Curtis
Journal: Ann Rheum Dis Date: 2013-07-13 Impact factor: 19.103

Review 9. Could retinoids be a potential treatment for rheumatic diseases?

Authors: Yoshishige Miyabe; Chie Miyabe; Toshihiro Nanki
Journal: Rheumatol Int Date: 2014-06-18 Impact factor: 2.631

10. Biofilm formation by Pneumocystis spp.

Authors: Melanie T Cushion; Margaret S Collins; Michael J Linke
Journal: Eukaryot Cell Date: 2008-09-26